The Impact of HIV/AIDS on the Health Sector: National Survey of Health Personnel, Ambulatory and Hospitalised Patients and Health Facilities, 2002
HSRC Press, 2003 - History - 175 pages
This series of studies provides answers to three broad questions--"To what extent does HIV/AIDS affect the health system in South Africa?. What aspects or subsystems are most affected?, and "How will the impact progress over time? Health personnel and ambulatory and hospitalized patients across the nine provinces of South Africa were surveyed. Specific questions addressed issues such as loss of staff due to illness, absenteeism, low staff morale, and increased patient load. Taking into account the anticipated increase in patient load in the public and private sector health facilities in South Africa, the study makes recommendations not only for managing the HIV/AIDS case load, but also for the care and services provided to people with HIV/AIDS in South Africa.
What people are saying - Write a review
We haven't found any reviews in the usual places.
African health workers AIDS patients antibodies antiretroviral drugs associated with HIV/AIDS Bangui scale bed occupancy rates candidiasis Cape Eastern Cape cent CI 95 cent of health death disease district hospitals Eastern Cape Eastern estimated Family Health International fieldworkers health care facilities health care system health professionals health services HIV positive HIV status HIV test HIV/AIDS patients HIV/AIDS-related illness Human immunodeficiency virus impact of HIV/AIDS increase interviews KwaZulu-Natal length of stay living with HIV/AIDS medical wards mortality Mpumalanga Nevirapine NNRTI non-professional health workers North West Northern Cape nosocomial infection number of admissions number of patients nurses OCCUPATIONAL CATEGORY opportunistic infections oral ﬂuid paediatric wards Percentage of health PHC facilities positive predictive value private health sector private hospitals private sector public and private public hospitals PUBLIC PUBLIC PUBLIC questionnaires reported respondents sampling weight South Africa South African health specimen Statistics South Africa Table TB associated total number universal precautions unweighted workload
Page 144 - II) 1. candidiasis of the esophagus, trachea, bronchi, or lungs 2. cryptococcosis, extrapulmonary 3. cryptosporidiosis with diarrhea persisting >1 month 4. cytomegalovirus disease of an organ other than liver, spleen, or lymph nodes in a patient >1 month of age 5. herpes simplex virus infection causing a mucocutaneous ulcer that persists longer than 1 month; or bronchitis, pneumonitis, or esophagitis for any duration affecting a patient >1 month of age 6.
Page 144 - ... <13 years of age: septicemia, pneumonia, meningitis, bone or joint infection, or abscess of an internal organ or body cavity (excluding otitis media or superficial skin or mucosal abscesses), caused by Haemophilus, Streptococcus (including pneumococcus), or other pyogenic bacteria 2.
Page 144 - Isosporiasis with diarrhea persisting > 1 month • Kaposi's sarcoma at any age • Lymphoma of the brain (primary) at any age • Other non-Hodgkin's lymphoma of B-cell or unknown immunologic phenotype and the following histologic types...
Page 164 - B, et al. (1993) HIV infection and severe malnutrition: a clinical and epidemiological study in Burkina Faso, in AIDS 7: 103-108.
Page 164 - LC (1996) Salivary testing for human immunodeficiency virus type 1 infection in children born to infected mothers in Sao Paulo, Brazil. The Sao Paulo Collaborative Study for Vertical Transmission of HIV-1, in Pediatric Infectious Disease Journal 15: 787-90.
Page 45 - The specificity of the test is defined as the ability of the test to identify correctly those who do not have the disease.
Page 3 - South Africa has the largest number of people living with HIV/AIDS in the world.
Page 164 - Peralta, L, Constantine, N, Griffin Deeds, B, Martin, L & Ghalib, K (2001) Evaluation of youth preferences for rapid and innovative human immunodeficiency virus antibody tests...
Page 120 - Human immunodeficiency virus (HIV) disease resulting in malignant neoplasms; • B22 Human immunodeficiency virus (HIV) disease resulting in other specified diseases; • B23 Human immunodeficiency virus (HIV) disease resulting in other conditions; • B24 Unspecified human immunodeficiency virus (HIV) disease.